SINGAPORE, February 26, 2025 – Respiree, an AI/ML health technology startup, has received clearance from Singapore’s Health Sciences Authority (HSA) to extend the use of its RS001 cardio-respiratory wearable device to pediatric patients. This clearance also enables the expansion of Respiree’s software platform, introducing enterprise-grade pathway management services and Electronic Health Record (EHR) interoperability, further enhancing its innovative healthcare solutions.
The RS001 wearable directly measures cardio-respiratory data, now catering to both adult and pediatric populations. This device collects vital data through sensors, transmitting it to a cellular hub which then displays information on a user-friendly, connected dashboard. Respiree’s updated software solution now offers integrated pathway management services, empowering physicians to provide personalized care through advanced monitoring capabilities in the patient’s home.
Key features include:
- Automated alert setup and symptom questionnaire generation
- Seamless integration with Electronic Health Records (EHR) systems
- Interoperability through external API plugins
WHY IT MATTERS
“This significant regulatory extension allows Singapore’s healthcare systems, and those internationally, to accurately capture and leverage cardio-respiratory data for a wider pediatric population,” said Dr. Gurpreet Singh, CEO and Founder of Respiree. “Furthermore, Respiree’s software platform streamlines workflow integration, supporting smoother transitions across care settings, including transitions from hospitals to homes through our new pathway management services. This improvement enables more efficient and streamlined care.”
With the expanded HSA clearance, Respiree is focused on securing more regulatory approvals in other Asia-Pacific regions, including the USA, within the next few months. The company also plans to seek clearances for its AI-powered Software-as-a-Medical-Device (SaMD), which will integrate into its existing enterprise solution, bolstering its capabilities and impact on patients’ lives.
About Respiree Respiree™ is an AI/ML health tech company developing clinically-validated AI for managing disease progression. Respiree™ is CE marked and has received regulatory clearances from the Therapeutic Goods Administration and the United States Food and Drug Administration (FDA).
